Electrophysiological study of the effects of the reuptake inhibitor duloxetine on serotonergic responses in the aging hippocampus

Pharmacology

Volumn 55, Issue 2, 1997, Pages 66-77

  Smith, Jane E ^a   Lakoski, Joan M ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Aging; Cellular electrophysiology; Duloxetine; Hippocampus; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORAL HYDRATE; DULOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0030879669     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139514     Document Type: Article

References (58)

1. Murphy DL. Mueller EA, Garrick NA, Aulakli CS: Use of serotonergic agents in the clinical assessment of central serotonin function. J Clin Psychiatry 1986:47:9-15.
2. Owens MJ. Ncmerof TCB: Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 1994:40: 288-295.
3. Levkovitz Y. Richter-Levin G, Segal M: Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats. Neuro-biol Aging 1994;15:635-641.
4. Asberg M. Thoren P, Traskman L: ‘Serotonin depression': A biochemical subgroup within the affective disorders? Science 1976:191:478-480.
5. Perry EK. Marshall EF. Blessed G. Tomlinson BE. Perry RH: Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 1983:142: 188-192.
6. Mann JJ. Stanley M, McBride PA. McEwen BS: Increased serotonin and p-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 1986:43: 954-959.
7. Gozlan H, Daval G, Verge D, Spam-pinato U, Fattaccini CM, Gallissot MC, El Mestikarvy S, Hamon M: Aging associated changes in serotonergic and dopaminergic pre-and postsynaptic neurochemical markers in the rat brain. Neurobiol Aging 1990;11:437-449.
8. Moretti A, Carfagna N, Trunzo F: Effect of aging on monoamines and their metabolites in the rat brain. Neurochem Res 1987; 12:1035-1039.
9. Tanila H, Taira T, Piepponen TP, Honkanen A: Effect of sex and age on brain monoamines and spatial learning in rats. Neurobiol Aging 1994;15:733-741.
10. Venero JL, de la Roza C, Machado A. Cano J: Age-related changes on monoamine turnover in hippocampus of rats. Brain Res 1993:631:89-96.
11. Burnet PWJ. Eastwood SL, Harrison PJ: Detection and quantitation of 5-HTIA and 5-HT2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age. Ncu-rosciLett 1994:178:85-89.
12. Marcusson J. Oreland L, Winblad B: Effect of age on human brain serotonin (S-l) binding sites. J Ncuro-chem 1984:43:1699-1705.
13. Arora RC, Gulati A, Crayton JW: Aging and 'H-paroxetine binding in the rat brain: Effect of imipramine and tctrahydroacridisne. Life Sci 1993;52:1767-1775.
14. Dugar A, Lakoski JM: Serotonergic function of aging hippocampal CA3 pyramidal neurons: Electrophysio-logical assessment following administration of 5,7-dihydroxytryptam-ine in the fimbria-fornix and cingulum bundle. J Ncurosci Res 1997; 47:58-67.
15. Pineyro G, Blier P, Dennis T, de Montigny C: Dcsensitization of the neuronal 5-HT carrier following its long-term blockade. J Ncurosci 1994;14:3036-3047.
16. Sheard MH, Zolovick A, Aghaja-nian GK: Raphe neurons: Effect of tricyclic antidepressant drugs. Brain Res 1972:43:690-694.
17. Bouthillier A. de Montigny C: Longterm antidepressant treatment reduces neuronal responsiveness to flurazepam: an electrophysiological study in the rat. Ncurosci Lett 1987; 73:271-275.
18. de Montigny C, Chaput Y, Blier P: Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers. J Clin Psychiatry 1990;51:4-8.
19. Landfteld PW. Lynch G: Impaired monosynaptic potentiation in in vitro hippocampal slices from aged, memory-deficient rats. J Gerontol 1977;32:523-533.
20. Landficld PW. McGaugh JL. Lynch G: Impaired synaptic potentiation processes in the hippocampus of aged, memory deficient rats. Brain Res 1978:150:85-101.
21. Landficld PW. Wurtz C, Lindsey JD: Quantification of synaptic vesicles in hippocampus of aging rats and initial studies of possible relations to neurophysiology. Brain Res Bull 1979:4:757-763.
22. Lippa AS. Critchett DJ. Ehlcrt F, Yamamura HI. Enna SJ, Bartus RT: Age-related alterations in neurotransmitter receptors: An electro-physiological and biochemical analysis. Neurobiol Aging 1981;2:3-8.
23. Piller TA, Landfteld PW: Aging-related prolongation of calcium spike duration in rat hippocampal slice neurons. Brain Res 1990,508: 1-6.
24. Segal M: Changes in neurotransmit-tcr actions in the aged rat hippocampus. Neurobiol Aging 1982;3:121-124.
25. Arentsen MI. Lakoski JM: Cellular electrophysiology of 5-HT, v-me-diated responses in CA1 and CA3 hippocampal subfields with aging. Soc Neurosci Abstr 1993:19:1060.
26. Wong DT. Bymaster FP. Mayie DA. Reid LR. Krushinski JH. Robertson DW: LY248686: A new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacologv 1993;8:23-33.
27. Engleman EA, Robertson DW, Thompson DC, Perry KW, Wong DT: Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus. J Neurochem 1996:66: 599-603.
28. Kasamo K. Blier P, de Montigny C: Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain. J Pharmacol Exp Ther 1996;277:1067-1075.
29. Kihara T, Ikeda M: Effects of duloxetine. a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J Pharmacol Exp Ther 1995:272:177-183.
30. Katoh A. Eigyo M. Ishibashi C. Nai-toh Y, Takcuchi M, Ibii T. lkcda M. Matsushita A: Behavioral and clec-trocncephalographic properties of duloxetine (LY248686), a reuptake inhibitor of norepinephrine and serotonin. in mice and rats. J Pharmacol ExpTher 1995:272:1067-1075.
31. Englcman EA, Perry KW, Mayle DA. Wong DT: Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine. a dual serotonin and norepinephrine uptake inhibitor. Neuropsychopharmacology 1995:12:287-295.
32. Fuller RW, Hcrmick-Luecke SK. Snoddy HD: Effects of duloxetine. an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. J Pharmacol Exp Ther 1994: 269:132-136.
33. Shaw DM. Camps FE. Eccleston EG: 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry 1967; 113:1407-1411.
34. Nelson JC. Mazure CM. Bowers MB. Jatlow PI: A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991:48:303-307.
35. Seth R. Jennings AL. Bindman J. Phillips J. Bergmann K: Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 1992:161:562-565.
36. Kohler KC. Stcinbusch H: Identification of serotonin and non-seroton-in-containing neurons in the midbrain raphe projecting to the entor-hinal area and the hippocampal formation. A combined immunohisto-chcmical and fluorescent retrograde tracing study in the rat brain. Neuroscience 1982:7:951-975.
37. Finch CE, Felicio LS. Mobbs CV, Nelson JF: Ovarian and steroidal influences on neuroendocrine aging processes in female rodents. Endocr Rev 1984;5:467-497.
38. Lakoski JM: Neuroendocrinology of aging at the cellular level: Membranes to neural circuits. Ncurobiol Aging 1994:15:519-520.
39. Wise PM: Agingof the female reproductive system. Rev Biol Res Aging 1983;1:195-222.
40. Weissman MM. Klcrman GL: Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977:34:98-111.
41. Weissman MM, Olfson M: Depression in women: Implications for health care research. Science 1995; 269:799-801.
42. Ople HR. Stcinmann MW: The effect of vincamine. hydergineand piracetam on the firing rate of locus eoeruleus neurons. J Neural Trans 1982;55:101-109.
43. Smith JE. Lakoski JM: Elcctrophysi-ological effects of fluoxetine and du-loxctine in the dorsal raphe nucleus and hippocampus. F.ur J Pharmacol 1997;323:69-73.
44. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, cd 2. New York, Academic Press, 1986.
45. Salmoiraghi GC. Weight F: Micromethods in neuropharmacology: An approach to the study of anesthetics. Anesthesiology 1967;28:54-64.
46. Kandcl ER, Spencer WA: Electro-physiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 1961:24:243-259.
47. de Montigny C, Aghajanian GK: Preferential action of 5-mcthoxydi-methvltryptamine on presynaptic serotonin receptors: A comparative iontophorctic study with LSD and 5-HT. Neuropharmacology 1977; 16:811-818.
48. de Montigny C. Wang RY. Reader TA. Aghajanian GK: Monoaminer-gic denervation of the rat hippocampus: microionlophoretic studies on pre-and postsynaptic supersensitivity to norepinephrine and serotonin. Brain Res 1980;200:363-376.
49. 3H]5-HT binding in the CNS of female Fischer 344 rats. Ncurosci Lett 1989:101:293-298.
50. Barnes CA. McNaughton BL: Physiological compensation for loss of afferent synapses in rat hippocampal granule cells during senescence. J Physiol 1980:309:473-485.
51. Geinisman Y. Bondarcff W: Decrease in the number of synapses in the senescent brain: A quantitative electron microscopic analysis of the dentate gyrus molecular layer in the rat. Mcclt Age Dev 1976;5:11-23.
52. Bickford-Wimer PC. Miller JA, Freedman R, Rose GM: Age-related reduction in responses of rat hippocampal neurons to locally applied monoamines. Neurobiol Aging 1988:9:173-179.
53. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B. Kapatos G: Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sei USA 1992:89:7095-7099.
54. Cunningham KA. Lakoski JM: The interaction of cocaine with serotonin dorsal raphe neurons: Single-unit extracellular recording studies. Ncu-ropsychopharmacology 1990;3:41-50.
55. Segal M. Bloom F: The action of norepinephrine in the rat hippocampus. I. Iontophorctic studies. Brain Res 1974:72:79-97.
56. Blazer D, Williams CD: Epidemiology of dysphoria and depression in an elderly population. Am J Psychiatry 1980;137:439-444.
57. Procter AW. Bowen DM: Aging: The cerebral cortex, and psychiatric disorder: in Davies P. Finch CE (eds): Molecular Neuropathology of Aging. New York, Cold Spring Harbor Laboratory', 1987. pp 3-20.
58. Roth M: Problems of an ageing population. Br Med J 1960;i: 1226-1230.